Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

The New Normal for Clinical Trials and Planning for the Future Webinar
Tuesday, October 6, 2020
8am PDT/11 am EDT/4pm BST

Presented by Dr. Theodore Search, Skipta CEO; and Loni Branon, Senior Director for Citeline

Our panel of industry experts will discuss the impact of COVID-19 on clinical trials, the new normal and key considerations for future planning –  Register now to be part of this important session to help you get ahead

What you'll hear
  • How has COVID-19 impacted clinical trials? 
  • What barriers still exist?
  • What do investigators, patients, and industry need in order to continue making progress in trials? 
  • Have investigators seen an increase in the diversity of participants?
  • How quickly and successfully has industry pivoted to decentralized/hybrid design trials?

Our Panel

Dr. Theodore Search

Skipta, CEO

Dr. Theodore Search, Pharm. D. is an innovation advocate, entrepreneur, tech guru, and expert in healthcare. He has been invited to speak at various healthcare and technology conferences around the world and named amongst the Top 100 Most Inspiring People in the Life Sciences Industry in 2015 and amongst the Top 100 Elite Entrepreneurs in the pharmaceutical and healthcare industry in 2016.

Loni Branon

Senior Director, Citeline

Loni Branon is Senior Director of Citeline’s Sitetrove, the pharma industry’s most comprehensive clinical investigator and trial site intelligence solution, and Citeline Engage, which combines the industry’s most comprehensive clinical trial intelligence suite with the leading online community of verified healthcare professionals (HCPs) powered by Skipta.

Vallerie McLaughlin, MD

Cardiologist clinical trial investigator

Dr. Vallerie McLaughlin is Professor of Cardiovascular Medicine and Director of the Pulmonary Hypertension Program at the University of Michigan in Ann Arbor. She is a Principal Investigator of several major clinical trials of drug therapies for pulmonary arterial hypertension and has published numerous papers in this field. Dr. McLaughlin is currently the PI for 5 clinical trials and is on the steering committee for trials currently in process or planning stages and as well as a DSMB member.

Marwan Fakih, MD

Oncologist clinical trial investigator

Dr. Marwan Fakih is Professor of Medical Oncology and Therapeutics Research, Judy and Bernard Briskin Distinguished Directorship in Clinical Research, Associate Director for Clinical Services, Medical Director, Briskin Center for Clinical Research, Co-director, Gastrointestinal Cancer Program; and Section Head, GI Medical Oncology.

Over the past 18 years, Dr. Fakih’s career focused on colorectal cancer research and clinical drug development (phase I/II trials). He has conducted numerous investigator-initiated trials in patients with solid tumors and colorectal cancer.

Complete the fields to register for your free place!

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio
By ticking this box, you agree to receive emails such as promotional offers from other members of the Informa group and selected 3rd party companies